Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative

Payam Sasanejad, Leila Afshar Hezarkhani, Shahram Arsang-Jang, Georgios Tsivgoulis, Abdoreza Ghoreishi, Barlinn Kristian, Jan Rahmig, Mehdi Farhoudi, Elyar Sadeghi Hokmabadi, Afshin Borhani-Haghighi, Payam Sariaslani, Athena Sharifi-Razavi, Kavian Ghandehari, Alireza Khosravi, Craig Smith, Yongchai Nilanont, Yama Akbari, Thanh N. Nguyen, Anna Bersano, Nawaf YassiTakeshi Yoshimoto, Simona Lattanzi, Animesh Gupta, Ramin Zand, Shahram Rafie, Seyede Pourandokht Mousavian, Mohammad Reza Shahsavaripour, Shahram Amini, Saltanat U. Kamenova, Aida Kondybayeva, Murat Zhanuzakov, Elizabeth M. Macri, Christa O.Hana S. Nobleza, Sean Ruland, Anna M. Cervantes-Arslanian, Masoom J. Desai, Annemarei Ranta, Amir Moghadam Ahmadi, Mahtab Rostamihosseinkhani, Razieh Foroughi, Etrat Hooshmandi, Fahimeh H. Akhoundi, Ashfaq Shuaib, David S. Liebeskind, James Siegler, Jose G. Romano, Stephan A. Mayer, Reza Bavarsad Shahripour, Babak Zamani, Amadene Woolsey, Yasaman Fazli, Khazaei Mojtaba, Christian F. Isaac, Jose Biller, Mario Di Napoli, M. Reza Azarpazhooh

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number106121
JournalJournal of Stroke and Cerebrovascular Diseases
Volume30
Issue number12
DOIs
StatePublished - Dec 2021
Externally publishedYes

ASJC Scopus Subject Areas

  • Surgery
  • Rehabilitation
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Keywords

  • COVID-19
  • Disability
  • Longitudinal study
  • Outcomes
  • Safety
  • Stroke
  • Stroke severity
  • Thrombolytic therapy
  • death

Cite this